Science Explorer Interactive view Map
Company · Tübingen · Germany

Immatics Biotechnologies (Germany)

immatics.comROR OpenAlex
Research works
57
▲ 12% vs 2013–17
Citations
2.5k
44.1 per fractional work
Top-10% rate
12.5%
record average 16.5%
Open access
51%
world 28%

Not ranked overall: Immatics Biotechnologies (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.09× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 26.40× its world share, 3 worksImmunology and Micro…Neuroscience: 0.26× its world share, 0 worksNeuroscienceEngineering: 0.04× its world share, 0 worksEngineeringMaterials Science: 0.14× its world share, 0 worksMaterials ScienceMedicine: 3.16× its world share, 8 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 26.4×. Every wedge is a field page.

Who are the top researchers at Immatics Biotechnologies (Germany)?

Ranked on the composite score, Toni Weinschenk lead among researchers whose main affiliation is Immatics Biotechnologies (Germany).

  1. 1 Toni Weinschenk Germany · #603,399 worldwide 63 citations · 17 works
All ranked researchers at Immatics Biotechnologies (Germany)

Which keywords describe research at Immatics Biotechnologies (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Antigen Presentation, Immunotherapy, Innate Immunity, Immunity, Lymphoma, Tumor Regression and Dendritic Cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Immunotherapy18▲ 230×2 topics
  2. Antigen Presentation14▲ 241×2 topics
  3. Immunotherapy10▲ 27×8 topics
  4. Innate Immunity10▲ 49×5 topics
  5. Immunity10▲ 50×4 topics
  6. Lymphoma10▲ 113×2 topics
  7. Tumor Regression9▲ 189×2 topics
  8. Dendritic Cells9▲ 141×1 topic
  9. Tumor Antigen9▲ 199×1 topic
  10. CAR T Cells9▲ 369×1 topic
  11. Chimeric Antigen Receptor9▲ 369×1 topic
  12. Monoclonal Antibodies6▲ 80×2 topics
  13. Glycosylation6▲ 50×3 topics
  14. Tumor Microenvironment5▲ 27×5 topics
  15. Fc Receptors5▲ 93×1 topic
  16. Therapeutic Antibodies5▲ 72×1 topic
  17. Epitope Prediction4▲ 424×1 topic
  18. Peptide-MHC Binding4▲ 424×1 topic
  19. Immune Checkpoint Blockade4▲ 132×1 topic
  20. PD-1 and PD-L14▲ 132×1 topic
  21. NK Cell Recognition2▲ 42×1 topic
  22. Natural Killer Cells2▲ 42×1 topic
  23. PET Imaging2▲ 15×4 topics
  24. Cancer Therapy2▲ 4.6×7 topics
  25. Autoimmunity2▲ 13×2 topics
  26. Foxp32▲ 36×1 topic
  27. Prognostic Factors2▲ 5.7×7 topics
  28. TGF-ß2▲ 15×1 topic
  29. Angiogenesis1▲ 5.8×4 topics
  30. Biopharmaceuticals1▲ 33×2 topics
  31. Gene Therapy1▲ 8.4×4 topics
  32. Biosimilars1▲ 146×1 topic
  33. Immunogenicity1▲ 43×1 topic
  34. Immunosuppression1▲ 18×2 topics
  35. Stromal Cells1▲ 23×2 topics
  36. Fibroblast Activation Protein1▲ 37×1 topic
  37. N-terminal Acetylation1▲ 37×1 topic
  38. Rituximab1▲ 12×2 topics
  39. Biosphere Reserves1▲ 154×1 topic
  40. Therapeutic Targets1▲ 7.8×3 topics

Which research topics does Immatics Biotechnologies (Germany) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Immune Cell Function and Interaction, Monoclonal and Polyclonal Antibodies Research and Immunotherapy and Immune Responses.

CAR-T cell therapy resea…4CAR-T cell therapy research: 4 fractional worksImmune Cell Function and Interaction: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksT-cell and B-cell Immuno…1T-cell and B-cell Immunology: 1 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksvaccines and immunoinformatics approaches: 0 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksViral Infectious Diseases and Gene Expression in Insects: 0 fractional works
OncologyImmunologyRadiology, Nuclear Medicine and ImagingMolecular Biology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 4 works
  2. 2 Immune Cell Function and Interaction Immunology 1 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Immunotherapy and Immune Responses Immunology 1 works
  5. 5 T-cell and B-cell Immunology Immunology 1 works
  6. 6 Biosimilars and Bioanalytical Methods Immunology 0 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 0 works
  8. 8 vaccines and immunoinformatics approaches Molecular Biology 0 works
  9. 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  10. 10 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.2%not open48.8%

World: 28% of research is openly available.

with international co-authors39.6%domestic only60.4%

World: 19% is written across borders.

How has Immatics Biotechnologies (Germany)'s research output changed?

Output in 2018–2022 was 12% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tübingen

All research institutions in Tübingen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.